ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC38902-5mg |
|
74226-22-5 |
Dazoxiben
|
0 | C12H13ClN2O3 | |
GC38902-1mg |
|
74226-22-5 |
Dazoxiben
|
0 | C12H13ClN2O3 | |
GC38901-25mg |
|
61177-44-4 |
Clavulanate lithium
|
0 | C8H8LiNO5 | |
GC38901-10mg |
|
61177-44-4 |
Clavulanate lithium
|
0 | C8H8LiNO5 | |
GC38901-5mg |
|
61177-44-4 |
Clavulanate lithium
|
0 | C8H8LiNO5 | |
GC38900-5mg |
|
114906-74-0 |
Ciwujianoside C3
|
0 | C53H86O21 | |
GC38900-1mg |
|
114906-74-0 |
Ciwujianoside C3
|
0 | C53H86O21 | |
GC38899-100mg |
|
— |
CDK ligand for PROTAC hydrochloride
|
0 | C25H29ClF2N8O | |
GC38899-50mg |
|
— |
CDK ligand for PROTAC hydrochloride
|
0 | C25H29ClF2N8O | |
GC38899-25mg |
|
— |
CDK ligand for PROTAC hydrochloride
|
0 | C25H29ClF2N8O | |
GC38899-10mg |
|
— |
CDK ligand for PROTAC hydrochloride
|
0 | C25H29ClF2N8O | |
GC38899-5mg |
|
— |
CDK ligand for PROTAC hydrochloride
|
0 | C25H29ClF2N8O | |
GC38898-100mg |
|
1922098-69-8 |
CCG-222740
|
0 | C23H19ClF2N2O3 | |
GC38898-50mg |
|
1922098-69-8 |
CCG-222740
|
0 | C23H19ClF2N2O3 | |
GC38898-25mg |
|
1922098-69-8 |
CCG-222740
|
0 | C23H19ClF2N2O3 | |
GC38898-10mg |
|
1922098-69-8 |
CCG-222740
|
0 | C23H19ClF2N2O3 | |
GC38898-5mg |
|
1922098-69-8 |
CCG-222740
|
0 | C23H19ClF2N2O3 | |
GC38897-100mg |
|
— |
Carnostatine hydrochloride
|
0 | C10H17ClN4O4 | |
GC38897-50mg |
|
— |
Carnostatine hydrochloride
|
0 | C10H17ClN4O4 | |
GC38897-25mg |
|
— |
Carnostatine hydrochloride
|
0 | C10H17ClN4O4 | |